ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice

Zhang, Hongya; He, Fangyuan; Zhou, Linfu; Shi, Ming; Li, Fangming*; Jia, Hongge*南方医科大学; 西北大学
Biochemical and Biophysical Research Communications2022-5-7DOI: 10.1016/j.bbrc.2022.03.004
4被引20阅读
引用收藏
分享

摘要

Idiopathic inflammatory myopathy (IIM) is an autoimmune disease that invades skeletal muscle; however, the etiology of IIM is still poorly understood. Toll-like receptor (TLR) 4 has been widely reported to take part in the autoimmune inflammation of IIMs. The mammalian target of rapamycin, mTOR, is a key central substance which mediates immune responses and metabolic changes, and also has been confirmed to be involved in the pathogenesis of IIMs. However, the interconnectedness between TLR4 and mTOR in IIM inflammation has not been fully elucidated. We hypothesized that TLR4 may play an important role in IIM inflammatory muscle injury by regulating mTOR. Mice were divided into four groups: a normal control group, IIM animal model (experimental autoimmune myositis, EAM) group, TAK242 intervention group and rapamycin (RAPA) intervention group. The results of EAM mice showed that TLR4, mTOR, nuclear factor-kappa B (NF-kappa B) and inflammatory factors interleukin-17A (IL-17A) and interferon gamma (IFN-gamma) mRNA levels were significantly upregulated. These factors were positively correlated with the degree of muscle inflammatory injury. When EAM mice were given the antagonist TAK242 to inhibit the TLR4 pathway, the results demonstrated that both mTOR and NF-kappa B were downregulated in the muscle of the mice. Muscle staining showed that the inflammatory injury was alleviated and the EAM mouse muscle strength was improved. Then, RAPA was used to inhibit the mTOR pathway, and the inflammatory factors IL-17A and IFN-gamma were downregulated in EAM mouse muscle and serum. Consistently, muscle inflammatory injury was significantly reduced, and muscle strength was significantly improved. Our results suggest that TLR4 may regulate inflammatory muscle injury in EAM by activating the mTOR and NF-kappa B pathways, which provides both an experimental complement for the pathological mechanism of IIM and an encouraging target for the selection of effective treatments.

学科与关键词

关键词
Idiopathic inflammatory myopathyExperimental autoimmune myositisMuscle injuryInflammationToll-like receptor 4mTORNF-kappa B
相关
加载中…
  • Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-?B pathways in experimental autoimmune myositis mice (vol 603, pg 29, 2022)
    Zhang, Hongya; He, Fangyuan; Zhou, Linfu; Shi, Ming; Li, Fangming*; Jia, Hongge*Biochemical and Biophysical Research Communications, 2022, 606: 182-182.
  • JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway
    Lu, Yaru; Ma, Qian; Yu, Lu; Huang, Huan; Liu, Xiaoxi; Chen, Pei; Ran, Hao*; Liu, Weibin*International Immunopharmacology, 2023, 115: 109693.被引 4
  • mTORC2 contributes to systemic autoimmunity
    Zhou, Xian; Qi, Haiyu; Li, Meilu; Li, Yanfeng; Zhu, Xingxing; Amin, Shreyasee; Alexander, Mariam; Diadhiou, Catherine; Davidson, Anne; Zeng, Hu*Immunology, 2023, 168(3): 554-568.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical and Biophysical Research Communications
发表日期
2022-05-07
卷期
第 603 卷
页码
29-34
DOI
10.1016/j.bbrc.2022.03.004
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Basic Research Program of Shaanxi Province [2019JQ-115]; Natural Science Foundation of Shenzhen University General Hospital at China [SUGH2019QD008]

作者

  • Z

    Zhang, Hongya (第一作者)

    shenzhen univ

  • H

    He, Fangyuan

查看全部 6 位作者收起作者
  • Z

    Zhou, Linfu

    northwestern univ

  • S

    Shi, Ming

  • L

    Li, Fangming (通讯)

    shenzhen univ

  • J

    Jia, Hongge (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417